VITASPRING BIOMEDICAL CO., LTD. Net Income (Loss) Allocated to General Partners
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Net Income (Loss) Allocated to General Partners of -$20.04 thousand for the 9-month period ending 2018-10-31, per its 10-Q filed 2018-11-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:NetIncomeLossAllocatedToGeneralPartners · last filed 2018-11-21
- 2018-10-31: Net Income (Loss) Allocated to General Partners 9 month -$20.04K.
- 2017-10-31: Net Income (Loss) Allocated to General Partners 9 month -$2.48K.
| Period end | Net Income (Loss) Allocated to General Partners 9 month |
|---|---|
| 2018-10-31 | -$20.04K 10-Q · filed 2018-11-21 |
| 2017-10-31 | -$2.48K 10-Q · filed 2018-11-21 |